Patient considerations in the treatment of COPD: focus on the new combination inhaler fluticasone furoate/umeclidinium/vilanterol

Molino A, Calabrese G, Maniscalco M

Patient Preference and Adherence 2018, 12:993-1001

Published Date: 8 June 2018